Pfizer announced on Wednesday that its Covid-19 vaccine is 100% effective in youngsters ages 12 to 15. At this time, Pfizer CEO Albert Bourla said the organization intends to present the new information on the vaccine. The German pharmaceutical company BioNTech creates the vaccine in association with Pfizer. The Food and Drug Administration and different controllers as quickly as time permits, with the expectation that children within the age will actually want to get immunized before the following school year.

“We share the urgency to expand the authorization of our vaccine to use in younger populations and are encouraged by the clinical trial data from adolescents between the ages of 12 and 15,” Bourla said in a press release.

Moderna, AstraZeneca and Pfizer vaccine testing

Last week, Pfizer began testing the effective vaccine in children ages 6 months to 11 years. On contrary, Moderna also started a trial in similarly aged children last week. Moreover, AstraZeneca introduced a trial of its vaccine in 6- to 17-year-olds in February.

The test results

At this time, the preliminary trial enlisted 2,260 members in the United States. Additionally, 18 affirmed Covid-19 diseases saw in the fake treatment bunch. There are no affirmed contaminations in the group that got the antibody, the organization said. That brought about immunization adequacy of 100%, it said, adding that the shot was additionally all-around endured, with results commonly steady with those found in grown-ups.  


Undoubtedly, vaccinating kids is crucial to ending the pandemic, health officials and experts say. The country is unlikely to achieve collective immunity at the point when enough people in a given local area have antibodies against a particular disease until kids can get immunized, specialists say.

Read More: